SNG001 clinical trials

Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection

This study looks at a new inhaled medicine, SNG001, for people in intensive care with severe breathing problems from a viral infection. We want to see if it's safe and helps them get better faster, compared to usual care.